Incyte Corporation
MX ˙ BMV ˙ US45337C1027
SecurityMX:INCY / Incyte Corporation
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership39,159 shares
Latest Disclosed Value $ 3,685,645
Macquarie Group Ltd reports 38.81% decrease in ownership of INCY / Incyte Corporation

On May 15, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 39,159 shares of Incyte Corporation (MX:INCY) valued at $3,685,645 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 63,999 shares of Incyte Corporation. This represents a change in shares of -38.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INCYTE COM 45337C102 39,159 -24,840 -38.81 3,686 -41.70 0.0172
2026-02-13 2025-12-31 13F INCYTE COM 45337C102 63,999 -222,740 -77.68 6,321 -74.01 0.0276
2025-11-13 2025-09-30 13F INCYTE COM 45337C102 286,739 109,410 61.70 24,319 101.37 0.0284
2025-08-14 2025-06-30 13F INCYTE COM 45337C102 177,329 8,237 4.87 12,077 17.95 0.0148
2025-08-14 2025-03-31 13F/A-1 INCYTE COM 45337C102 169,092 14,845 9.62 10,238 0.13 0.0127
2025-05-15 2025-03-31 13F INCYTE COM 45337C102 178,112 23,865 9,693 0.0079
2025-02-14 2024-12-31 13F INCYTE COM 45337C102 154,247 41,922 37.32 10,226 37.73 0.0124
2024-11-14 2024-09-30 13F INCYTE COM 45337C102 112,325 0 0.00 7,425 9.03 0.0080
2024-08-09 2024-06-30 13F INCYTE COM 45337C102 112,325 -49,259 -30.49 6,810 -26.03 0.0078
2024-05-14 2024-03-31 13F INCYTE COM 45337C102 161,584 -17,017 -9.53 9,205 -17.92 0.0104
2024-02-14 2023-12-31 13F INCYTE COM 45337C102 178,601 11,686 7.00 11,214 16.29 0.0130
2023-11-14 2023-09-30 13F INCYTE COM 45337C102 166,915 72,453 76.70 9,643 64.00 0.0121
2023-10-27 2023-06-30 13F/A-2 INCYTE COM 45337C102 94,462 -24,991 -20.92 5,880 -31.89 0.0067
2023-10-12 2023-06-30 13F/A-1 INCYTE COM 45337C102 94,462 -24,991 5,880 0.0059
2023-08-14 2023-06-30 13F INCYTE COM 45337C102 94,462 -24,991 5,880 0.0060
2023-06-01 2023-03-31 13F/A-1 INCYTE COM 45337C102 119,453 5,759 5.07 8,633 -5.46 0.0103
2023-05-15 2023-03-31 13F INCYTE COM 45337C102 119,453 5,759 8,633 0.0079
2023-02-21 2022-12-31 13F INCYTE COM 45337C102 113,694 -20,842 -15.49 9,132 1.85 0.0108
2022-11-14 2022-09-30 13F INCYTE COM 45337C102 134,536 -505 -0.37 8,966 -12.60 0.0110
2022-08-17 2022-06-30 13F/A-1 INCYTE COM 45337C102 135,041 -1,416 -1.04 10,259 -5.34 0.0115
2022-08-15 2022-06-30 13F INCYTE COM 45337C102 135,041 -1,416 10,259 0.0037
2022-05-16 2022-03-31 13F INCYTE COM 45337C102 136,457 8,719 6.83 10,838 15.59 0.0082
2022-02-11 2021-12-31 13F Incyte Genomics COM 45337C102 127,738 -23,407 -15.49 9,376 -9.80 0.0078
2021-11-12 2021-09-30 13F INCYTE COM 45337C102 151,145 -5,146 -3.29 10,395 -20.94 0.0089
2021-08-13 2021-06-30 13F INCYTE COM 45337C102 156,291 31,159 24.90 13,149 29.30 0.0108
2021-05-14 2021-03-31 13F INCYTE COM 45337C102 125,132 -2,505 -1.96 10,169 -8.40 0.0144
2021-02-16 2020-12-31 13F INCYTE COM 45337C102 127,637 0 0.00 11,101 -3.08 0.0162
2020-11-13 2020-09-30 13F INCYTE COM 45337C102 127,637 38,499 43.19 11,454 23.59 0.0194
2020-08-11 2020-06-30 13F INCYTE COM 45337C102 89,138 -2,984 -3.24 9,268 37.39 0.0160
2020-05-15 2020-03-31 13F INCYTE COM 45337C102 92,122 26,622 40.64 6,746 17.96 0.0139
2020-03-18 2019-12-31 13F/A-2 INCYTE COM 45337C102 65,500 -300 -0.46 5,719 17.07 0.0082
2020-02-28 2019-12-31 13F/A-1 INCYTE COM 45337C102 65,500 0 5,719 0.0083
2020-02-14 2019-12-31 13F INCYTE COM 45337C102 65,500 -300 5,719 7,176.8603
2019-11-14 2019-09-30 13F INCYTE COM 45337C102 65,800 3,300 5.28 4,885 -8.00 0.0082
2019-11-06 2019-06-30 13F/A-2 INCYTE COM 45337C102 62,500 1,100 1.79 5,310 0.55 0.0090
2019-09-24 2019-06-30 13F/A-1 INCYTE COM 45337C102 62,500 0 5,310 0.0090
2019-08-14 2019-06-30 13F INCYTE COM 45337C102 62,500 1,100 5,310
2019-05-15 2019-03-31 13F INCYTE COM 45337C102 61,400 1,100 1.82 5,281 37.74 0.0090
2019-02-15 2018-12-31 13F INCYTE COM 45337C102 60,300 -100 -0.17 3,834 -8.12 0.0074
2018-11-15 2018-09-30 13F INCYTE COM 45337C102 60,400 0 0.00 4,173 3.11 0.0068
2019-03-21 2018-06-30 13F/A-1 INCYTE COM 45337C102 60,400 -47,800 -44.18 4,047 -55.11 0.0070
2018-08-14 2018-06-30 13F INGREDION COM 45337C102 60,400 -47,800 4,047
2018-05-11 2018-03-31 13F INCYTE COM 45337C102 108,200 42,153 63.82 9,016 41.32 0.0164
2018-02-14 2017-12-31 13F INCYTE COM 45337C102 66,047 -1,066 -1.59 6,380 -18.57 0.0113
2017-11-08 2017-09-30 13F INCYTE COM 45337C102 67,113 -5,460 -7.52 7,835 -14.26 0.0141
2017-08-14 2017-06-30 13F INCYTE COM 45337C102 72,573 -17,987 -19.86 9,138 -24.51 0.0167
2017-05-15 2017-03-31 13F Incyte COM 45337C102 90,560 -16,513 -15.42 12,105 12.75 0.0220
2017-03-30 2016-12-31 13F/A-1 Incyte COM 45337C102 107,073 65,344 156.59 10,736 172.83 0.0205
2017-02-15 2016-12-31 13F Incyte Common Stock 45337C102 107,073 10,736
2016-11-15 2016-09-30 13F Incyte Common Stock 45337C102 41,729 -8,881 -17.55 3,935 -2.79 0.0076
2016-09-14 2016-06-30 13F/A-1 Incyte COM 45337C102 50,610 -17,790 -26.01 4,048 -18.34 0.0079
2016-08-15 2016-06-30 13F Incyte COM 45337C102 50,610 4,048
2016-05-16 2016-03-31 13F Incyte Common Stock 45337C102 68,400 -27,330 -28.55 4,957 -52.27 0.0100
2016-02-16 2015-12-31 13F Incyte Common Stock 45337C102 95,730 -18,160 -15.95 10,385 -17.36 0.0213
2015-11-16 2015-09-30 13F Incyte Common Stock 45337C102 113,890 13,900 13.90 12,566 20.60 0.0269
2015-08-21 2015-06-30 13F/A-1 Incyte COM 45337C102 99,990 11,909 13.52 10,420 29.06 0.0206
2015-08-14 2015-06-30 13F Incyte COM 45337C102 99,990 10,420
2015-05-18 2015-03-31 13F INCYTE COMMON 45337C102 88,081 38,181 76.52 8,074 121.33 0.0158
2015-02-17 2014-12-31 13F INCYTE COMMON 45337C102 49,900 0 0.00 3,648 49.02 0.0075
2014-11-14 2014-09-30 13F INCYTE COMMON 45337C102 49,900 3,500 7.54 2,448 -6.53 0.0053
2014-08-14 2014-06-30 13F INCYTE COMMON 45337C102 46,400 4,000 9.43 2,619 15.43 0.0058
2014-05-15 2014-03-31 13F INCYTE CORP Common 45337C102 42,400 -83 -0.20 2,269 5.49 0.0039
2014-02-14 2013-12-31 13F INCYTE CORP Common Stock 45337C102 42,483 -56,046 -56.88 2,151 -42.78 0.0039
2013-11-14 2013-09-30 13F INCYTE CORP Common Stock 45337C102 98,529 -34,049 -25.68 3,759 28.87 0.0074
2013-08-16 2013-06-30 13F/A-1 INCYTE CORP COMMON 45337C102 132,578 132,578 2,917 0.0064
2013-08-14 2013-06-30 13F INCYTE CORP COMMON 45337C102 132,578 2,917 0.0064
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.